阳性白血病:多模式管理和治疗技术与甲型玻尿素毒素
Rengifo-Palacios Jaime Alberto1, Macías-Arias Paola Andrea2, Uribe-Posada Maria Paulina1
1Dermatology, Pontificia Bolivariana University, Medellín, Colombia.
Dermatology research and practice
|October 27, 2025
概括
在A型肉毒毒素 (BoNT-A) 注射后的眼结是一种罕见的并发症. 了解面部解剖学和采用诸如前BoNT-A应用等技术,可以有效地预防和管理这种情况.
科学领域:
- 审美医学是一种美学医学.
- 眼科医生 眼科 眼科
- 整形外科 整形外科 整形外科
背景情况:
- 在使用甲型玻尿素毒素 (BoNT-A) 的美容治疗后,尤其是在没有经验的注射者身上,可能会发生眼皮亡 (blepharoptosis).
- 这种并发症是由于毒素的扩散影响了上方眼 (levator palpebrae superioris) 肌肉,导致眼垂落.
- 虽然它通常在几个月内自发地消失,但它可能会导致患者的痛苦.
研究的目的:
- 审查面部解剖学在预防BoNT-A诱导并发症方面的重要性.
- 描述因子性白血病的分类和管理策略.
- 为了强调治疗这种疾病的前性BoNT-A应用技术.
主要方法:
- 在主要的电子数据库 (PubMed,MEDLINE,Embase,Google Scholar) 进行了全面的文献搜索.
- 搜索的重点是面部上部解剖学,预防,分类和治疗二次性到BoNT-A. iatrogenic白血病的治疗选择.
- 对临床病例进行了审查,以支持治疗策略.
主要成果:
- 由于BoNT-A扩散到上方部肌肉中,产生了阳性白性损伤.
- 目前的治疗方法包括眼滴,运动,射频和前BoNT-A应用.
- 重点放在解剖学知识和风险因素识别上,以尽量减少并发症.
结论:
- 了解面部解剖学对于最大限度地减少BoNT-A并发症,如白血病至关重要.
- 有效的管理策略,包括前BoNT-A技术,对于解决这种并发症至关重要.
- 虽然在训练有素的注射者中很少见,但白性死会产生显著的美学和功能影响.
相关概念视频
Open Angle Glaucoma: Treatment
953
In open-angle glaucoma, the iridocorneal angle remains open, but the trabecular meshwork becomes stiff, slowing down the outflow of aqueous humor. This causes a buildup of aqueous humor in the anterior chamber, leading to a sudden increase in intraocular pressure. The treatment for open-angle glaucoma focuses on reducing the elevated intraocular pressure by either decreasing the secretion of aqueous humor or increasing its outflow.
Drugs such as carbonic anhydrase inhibitors, α2- and...
Drugs such as carbonic anhydrase inhibitors, α2- and...
953
Angle Closure Glaucoma: Treatment
1.1K
Angle-closure glaucoma, or closed-angle glaucoma, is an eye condition where the iris bulges out and blocks the iridocorneal angle, resulting in a buildup of aqueous humor and increased intraocular pressure. Immediate medical attention is necessary due to the sudden onset of symptoms. The treatment for angle-closure glaucoma includes short-term and long-term approaches. Short-term treatment involves using eye drops like pilocarpine to lower intraocular pressure by increasing aqueous humor...
1.1K
Direct-Acting Cholinergic Agonists: Therapeutic Uses
1.6K
Direct-acting cholinergic agonists have many therapeutic uses in various medical fields. Choline esters, including acetylcholine, have limited clinical utility due to their non-selectivity and short duration of action. Still, acetylcholine and carbachol are applied topically during ophthalmologic surgery to induce miosis. Pilocarpine, a muscarinic and ganglionic stimulator, effectively treats open-angle glaucoma and alleviates xerostomia and dry mouth caused by radiotherapy or Sjögren...
1.6K
Myasthenia Gravis: Overview and Treatment
2.8K
Myasthenia gravis is a neuromuscular transmission disorder characterized by weakness and increased fatigability of skeletal muscles. It is an autoimmune disease affecting approximately one in 2000 people, where antibodies against the α1 subunit of nicotinic acetylcholine receptors are produced.
These antibodies interfere with the function of the nicotinic receptors in three ways: by binding to the receptor and disrupting acetylcholine binding; by causing cross-linking of receptors which...
These antibodies interfere with the function of the nicotinic receptors in three ways: by binding to the receptor and disrupting acetylcholine binding; by causing cross-linking of receptors which...
2.8K
Directly Acting Muscle Relaxants: Dantrolene and Botulinum Toxin
1.1K
Directly acting muscle relaxants like dantrolene and botulinum toxin (BoNT) have distinct mechanisms and applications. Dantrolene, a hydantoin derivative, acts on the ryanodine receptor (RYR1) in skeletal muscle cells. RYR1 are calcium channels present at the sarcoplasmic reticulum membrane. In response to excitation, they release calcium ions from the sarcoplasmic reticulum to the cytosol. Calcium promotes actin-myosin-mediated contraction of muscles.
The binding of dantrolene to the RYR1...
The binding of dantrolene to the RYR1...
1.1K


